Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B

Robert P. Perrillo, Ching‐Lung Lai, Yun‐Fan Liaw, Jules L. Dienstag, Eugene R. Schiff, Solko W. Schalm, E. Jenny Heathcote, Nathaniel A. Brown, Mark Atkins, Mary Woessner, Stephen D. Gardner – 30 December 2003 – Elevated alanine transaminase (ALT) levels and low serum hepatitis B virus (HBV) DNA predict a higher likelihood of hepatitis B e antigen (HBeAg) loss in patients with chronic hepatitis B treated with interferon. Predictors of HBeAg loss in patients treated with lamivudine are not known.

Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver

Hajime Honda, Kenichi Ikejima, Miyoko Hirose, Mutsuko Yoshikawa, Tie Lang, Nobuyuki Enomoto, Tsuneo Kitamura, Yoshiyuki Takei, Nobuhiro Sato – 30 December 2003 – In this study, we investigated hepatic fibrogenesis caused by long‐term thioacetamide (TAA) administration in ob/ob mice, a naturally occurring leptin deficient animal. In the lean littermates, prominent hepatic fibrosis, as well as positive staining for α smooth muscle actin (α‐SMA), was induced by treatment with TAA (200 μg/g, IP, 3 times per week) for 4 to 8 weeks as expected.

Bilirubin induces apoptosis via the mitochondrial pathway in developing rat brain neurons

Cecília M. P. Rodrigues, Susana Solá, Dora Brites – 30 December 2003 – Increased levels of unconjugated bilirubin, the end‐product of heme catabolism, are detrimental to the central nervous system. To examine the role of apoptosis in bilirubin‐induced toxicity and to characterize the biochemical pathway of cell death, we exposed developing rat brain neurons to purified unconjugated bilirubin at concentrations below and above saturation of human serum albumin. Isolated neurons treated with bilirubin showed increased levels of apoptosis.

Dose‐dependent inhibition of hepatic fibrosis in mice by a TGF‐β soluble receptor: Implications for antifibrotic therapy

Yutaka Yata, Philip Gotwals, Victor Koteliansky, Don C. Rockey – 30 December 2003 – Transforming growth factor (TGF) β isoforms (in particular, TGF‐β1) play a central role in the fibrogenic response to injury in many organs, including the liver. Although TGF‐β is clearly important in fibrogenesis, a number of issues related to therapeutic antagonism have emerged. For example, the long‐term effect of TGF‐β antagonism is unknown; furthermore, controversy exists as to appropriate levels of TGF‐β inhibition.

Relationship between acetaldehyde levels and cell survival in ethanol‐metabolizing hepatoma cells

Dahn L. Clemens, Andrew Forman, Thomas R. Jerrells, Michael F. Sorrell, Dean J. Tuma – 30 December 2003 – We have created a number of recombinant Hep G2 cell lines, designated VA cells, that constitutively express alcohol dehydrogenase. Oxidation of ethanol by the VA cells results in the production and accumulation of acetaldehyde, and a dramatic increase in the nicotinamide adenine dinucleotide, reduced (NADH)/nicotinamide adenine dinucleotide (NAD+) ratio (redox‐state).

Subscribe to